Physician profile
Alexandra Mcdaniel
NPI 1972964807
$5,185.57
in general payments reported to CMS, 2019-2025
13 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.05 · 2022: $116 · 2023: $4,629 · 2024: $258 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Food and Beverage | $538.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,565.41 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Coopersurgical, INC. | $170.27 | 2024-2025 | Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Myovant Sciences INC. | $103.79 | 2022 | |
| Hologic Sales and Service, LLC | $85.95 | 2024-2025 | Acessa Provu System, Aptima |
| Sumitomo Pharma America, INC. | $63.46 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $51.18 | 2024-2025 | Veozah |
| Optumhealth Care Solutions, LLC | $37.26 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Ethicon US, LLC | $26.40 | 2023 | Stratafix |
| Mayne Pharma Commercial LLC | $25.55 | 2023 | |
| Allergan, INC. | $16.51 | 2021 | |
| Avion Pharmaceuticals | $14.54 | 2021 | |
| Pfizer INC. | $13.32 | 2024 | |
| Daiichi Sankyo INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.